ID   CAVEOC-2
AC   CVCL_D308
DR   Wikidata; Q54808632
RX   PubMed=8615606;
RX   PubMed=8913435;
CC   Doubling time: 33 hours (PubMed=8615606).
CC   Miscellaneous: Cell line no longer available (personal communication of Merlin, Jean-Louis).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
RX   PubMed=8615606;
RA   Griffon-Etienne, Genevieve
RA   Merlin, Jean-Louis
RA   Parache, Robert-Michel
RA   Martinet, Nadine
RA   Marchal, Sophie
RA   Nabet, Francine
RA   Wellman, Maria
RA   Barlier, Catherine
RA   Marchal, Christian
RT   "Sensitivity to taxoid derivatives of a newly established human
RT   endometrioid ovarian adenocarcinoma radioresistant cell line.";
RL   Anticancer Res. 16:177-187(1996).
//
RX   PubMed=8913435; DOI=10.1097/00001813-199608000-00007;
RA   Griffon-Etienne, Genevieve
RA   Merlin, Jean-Louis
RA   Marchal, Christian
RT   "Association of docetaxel/paclitaxel with irradiation in ovarian
RT   carcinoma cell lines in bidimensional (sulforhodamine B assay) and
RT   tridimensional (spheroids) cultures.";
RL   Anticancer Drugs 7:660-670(1996).
//